1-methyl-3-isobutylxanthine has been researched along with oxidopamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaikh, IM; Skala, JP | 1 |
| Van Buskirk, R; Watling, KJ | 1 |
| Jones, DJ; Simmons, KE | 1 |
| Axer, H; de Vente, J; Emson, PC; Markerink-van Ittersum, M; Steinbusch, HW; van Abeelen, J | 1 |
| Aceves, J; Erlij, D; Florán, B; Floran, L; García-Ramírez, M; Rangel-Barajas, C; Sánchez-Lemus, E; Silva, I | 1 |
5 other study(ies) available for 1-methyl-3-isobutylxanthine and oxidopamine
| Article | Year |
|---|---|
Alpha 2-adrenergic receptors in brown adipose tissue of infant rats--II. Studies on function and regulation.
Topics: 1-Methyl-3-isobutylxanthine; Adenylate Cyclase Toxin; Adipose Tissue, Brown; Animals; Clonidine; Colforsin; Hydroxydopamines; Kinetics; Lipolysis; Oxidopamine; Pertussis Toxin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sympathectomy, Chemical; Virulence Factors, Bordetella; Yohimbine | 1988 |
Pharmacological properties and localization of dopamine-sensitive adenylate cyclase in the carp retina.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Calcium Chloride; Carps; Cyclic AMP; Dopamine; Haloperidol; Hydroxydopamines; In Vitro Techniques; Oxidopamine; Potassium; Retina; Retinal Ganglion Cells; Synapses | 1984 |
6-Hydroxydopamine treatment of neonatal rats. I. Effects on the development of the spinal cord noradrenergic system.
Topics: 1-Methyl-3-isobutylxanthine; Aging; Animals; Animals, Newborn; Cyclic AMP; Dihydroalprenolol; In Vitro Techniques; Kinetics; Norepinephrine; Organ Specificity; Oxidopamine; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Spinal Cord; Synaptosomes | 1993 |
NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis.
Topics: 1-Methyl-3-isobutylxanthine; 5,7-Dihydroxytryptamine; Acetylcholine; Animals; Carrier Proteins; Caudate Nucleus; Cholinergic Fibers; Cyclic GMP; Dopamine; Enzyme Induction; Excitatory Amino Acid Transporter 2; Frontal Lobe; Glutamate Decarboxylase; Male; Membrane Transport Proteins; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxidopamine; Parvalbumins; Prosencephalon; Putamen; Rats; Rats, Inbred Lew; Receptors, Neurotransmitter; Serotonin; Stereotaxic Techniques; Tyrosine 3-Monooxygenase; Vesicular Acetylcholine Transport Proteins; Vesicular Transport Proteins | 2000 |
6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Cyclic AMP; Disease Models, Animal; Dopamine Agents; Functional Laterality; gamma-Aminobutyric Acid; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Receptors, Dopamine D1; Substantia Nigra; Time Factors; Tritium | 2008 |